XML 77 R50.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED ENTITIES AND ACQUISITIONS - La Jolla Pharmaceutical Company (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Aug. 22, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]        
Change in inventory   $ (280) $ 0 $ 0
La Jolla Pharmaceutical Company        
Business Acquisition [Line Items]        
Total consideration paid $ 206,600      
Acquisition share price $ 6.23      
Measurement period adjustments for change in value of goodwill   3,700    
Change in inventory   (7,700)    
Measurement period adjustments for change in value of intangible assets   (1,500)    
Measurement Period Adjustments Increase Decrease In Liabilities   (8,300)    
Acquisition-related costs   5,300    
Measurement period adjustments increase decrease in deferred tax liabilities   $ 2,600